Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Critical Biologics Corp.
DescriptionIntravenous formulation of recombinant human plasma gelsolin (rhu-pGSN)
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard Indication Hematology (unspecified)
Indication DetailsTreat hypogelsolinemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today